Monthly Archives: April 2018
The Goal of Armored CAR T Cells
Dr. Renier Brentjens, MD, PhD from the Memorial Sloan Kettering Cancer Center, discusses the goal of armored CAR T-cells. He talks about how the...
‘Cross-dressing’ cells may improve cancer treatment
January 23, 2018 (Medical News Today)
A group of researchers from Switzerland are now focused on improving ‘dendritic cell vaccines’, which are an important...
CAR T-Cell Therapy HCP Guide – The Costs Involved in CAR T-Cell Therapy
Costs and Payer Questions
A patient-specific and complicated manufacturing process such as CAR T is expected to be costly. The cost of the first...
The state of cancer: Are we close to a cure?
March 2, 2018 (Medical News Today)
At present, the most common types of treatment for cancer – the leading cause of death – are chemotherapy,...
Immunotherapy for Glioblastoma: On the Sidelines or in the Game?
November 28, 2017 (Discovery Medicine)
Glioblastoma remains a major unmet medical need in the field of oncology. With less than 10% of patients surviving five...
